Abstract. Transcription levels of the genes on X chromosome are regulated through the dosage compensation mechanisms. The dosage compensation complex (DCC) localizes to X chromosome and activates the transcription of target genes in male 2-fold more than in female. Drosophila maleless (MLE), an ATPase/helicase, is a component of the DCC and essential for the viability of male flies. However, the functions of MLE on gene expression are not clear. RNA helicase A (RHA) is a homologue of Drosophila MLE and mediates the expression of several genes. RHA recruits preinitiation complex via the minimal transactivation domain (MTAD), consisting of 50 amino acids to target promoters. The tryptophan residues in MTAD are important for transactivation via RHA. The amino acid sequence of MTAD is conserved in MLE. In this study, we assessed whether the functions of MTAD are conserved in fruit fly by investigating the transcriptional activity of MLE. Transactivation assay indicated the MTAD of MLE had transcriptional activity in Schneider's cells. In vitro binding assays revealed that MLE recruited RNA polymerase II (Pol II) complexes through MTAD. Reporter assays showed that the MTAD, especially tryptophan residues, is important for transcription from roX promoter, similar to RHA. The results confirm that MTAD of MLE mediates the expression of MLE target genes through recruitment of Pol II.
Introduction
Drosophila males have a single X chromosome, while females have two X chromosomes. In male flies, the dosage compensation mechanisms elevate the level of transcription derived from a single X chromosome to a level equivalent to that derived from the two X chromosome in the female (1) . To date, five proteins; the dosage compensation complex (DCC), male-specific lethal 1 (MSL-1) (2,3), male-specific lethal 2 (MSL-2) (4), male-specific lethal 3 (MSL-3) (5), male absent on the first (MOF) (6) and maleless (MLE) (7), have been identified by genetic analysis. Only the expression of MSL-2 is limited to Drosophila male (8) . Loss-of function of these proteins results in male-specific lethality (9) . In addition to these proteins, two noncoding RNAs; RNA on the X1 (roX1) and RNA on the X2 (roX2), which are the target genes of the DCC on the X chromosome, are also involved in this complex (10) (11) (12) . It is well known that lysine 16 of histone H4 (H4K16) on X chromosome is highly acetylated in male flies (13, 14) . The DCC colocalizes with the acetylated lysines.
The dosage compensation mechanism is divided into two steps (15, 16) . In the first step, MSL-1 and MSL-2 form a core complex. This immature complex binds to 35 chromatin entry sites on the X chromosome and activates the transcription of target genes, including roX1 and roX2 genes (17, 18) . In the second step, other components, such as MOF, MSL-3, roX RNAs and MLE, are recruited into the core complex to form the mature DCC. Subsequently, the DCC spreads onto the X chromosome and targets hundreds of the specific sites. MSL-1, MSL-2 and MSL3 are thought to have structural and scaffold roles (19) , whereas MOF is a histone acetyltransferase, a member of the MYST family, and acetylates histone H4 on lysine 16 (6, 20) . The noncoding RNAs, roX1 and roX2 genes, have little sequence homology to each other and the DNaseI hypersensitive site (DHS) in the genome. It is thought that the DCC are recruited to the DHS and activate the expression of the genes (18, 21, 22) . These RNAs contribute to the correct localization of the DCC on X chromosome (23) . MSL-2, MSL-3 and MOF bind with MSL-1 via distinct domain (24) , while MLE, which can bind nucleic acids (33) , interacts with the complex through roX RNA, its recruitment of MLE on the X chromosome is RNase-sensitive (25) . MLE is an ATPase/ helicase and an essential factor for the development of fruit fly (26) . Spontaneous MLE null mutant (mle 1 ) has been identified and the homozygous mle 1 male die during the larval stage (27) . The enzymatic activity of this protein is necessary for the dosage compensation (25, 26) .
Mechanisms, which are different from Drosophila, regulate the products of gene expression from X chromosome in mammalian cells. The mammalian cells have genes coding the components of the DCC except for roX RNAs (28, 29) . Human MSL proteins are reported to work as a histone acetyltransferase complex, however the details are still unknown (30) . While the functions of MLE in Drosophila dosage compensation remain to be elucidated, many functions of RNA helicase A (RHA), a mammalian homologue of MLE (31), on gene expression were delineated by our group (32) (33) (34) .
RHA belongs to the DExH helicase/ATPase family and unwinds both of double-stranded RNA and DNA from 3' to 5'. RHA has several functional domains (35) (36) (37) . There are two double-stranded RNA binding domains, dsRBDI and dsRBDII in the amino terminus of RHA. The catalytic core domain contains well-conserved motifs and the ATP binding site, and is located in the central region of RHA (38) . The minimal transactivation domain (MTAD) is next to the ATP binding site (39) . The carboxyl terminus region contains glycine-rich single-stranded nucleic acid binding domain (RGG) and the nuclear localization signal (NLS) (40, 41) . RHA and MLE have 50% sequence identity and 90% similarity to each other (31) .
RHA has various functions at several stages of gene expression in mammalian cells. We reported previously that RHA interacts with the cAMP responsive element binding protein (CREB) binding protein (CBP) and mediates the recruitment of RNA polymerase II (Pol II) complexes through MTAD to promoters (34, 39) . RHA also regulates several transactivations, such as BRCA1 (42) , the activation function domain of mineralocorticoid receptor (43) . RHA activates transcription by binding to nucleic acids, such as the cis-acting transactivation response element (TAR) of HIV-1 (33) and the p16INK4a promoter (44) .
Several studies have emphasized the importance of RHA. The present study was designated to establish transcription and to verify that MTAD of MLE acts as transactivation domain in fly cells such as RHA in mammalian cells. We indicated that MTAD was included in the recruitment of Pol II to the DCC and regulated transcription from X chromosome, and that MLE acts as a transcriptional regulator not as a complex.
Materials and methods

Plasmids.
To construct the mle transgene, a SpeI/XbaI fragment that included the mle gene and the franking region (7) was isolated from Drosophila genomic library using the C terminal region of mle (Research Genetics) as a probe. This 10.2 kb fragment was filled in pCaSpeR4. For the deletion mutant transgene, the ΔMTAD fragment was generated by PCR and substituted for wild-type transgene. The expression vector in Drosophila cells, pBlue-Actin5C, in cells was constructed by inserting Actin5C promoter derived from pWA GAL4 into pBluescript II. The full length cDNAs coding MLE and the deletion mutant including MTAD (amino acids 219-653), termed MLE2, were generated by PCR and subcloned into pBlue-Actin5C. Amino acids 326-378 were deleted from MLE2 and full length MLE to generate MLE2ΔMTAD and MLEΔMTAD, respectively. The mutants with substitutions of amino acids were also made by PCR. For glutathione S-transferase pull down assay the full-length and MLE2 fragments were inserted into the bacterial expression vector pGEX-6P-1 (Amersham). There tryptophan residues in the MTAD region were substituted with alanine, phenylalanine or leucine and these mutants were termed MTADW328A, MTADW328F, MTADW328L, MTADW335A, MTADW335F, MTADW335L, MTAD-W338A, MTADW338F and MTADW338L. Each of these fragments was inserted and fused to the GAL4 DNA binding domain (GAL4-DBD), into pBlue-Actin5C or pcDNA3 (Invitrogen), for transactivation assays in Drosophila or mammalian cells, respectively. The plasmids encoding the enhanced green fluorescent protein fusion protein (GFP-MLE) were constructed by inserting fragments of the MLE wild-type and each mutants into pEGFP-C2 (Clontech Laboratories). The C-terminal deletion mutant (MLEΔEN), from which was deleted the amino acid region 1163 to 1287, was generated by PCR and inserted into pEGFP-C2. For reporter assay, the G14-ts/BasicVector2 was constructed by subcloning 14 UAS fragments and transposase promoterderived from pUASp into BasicVector2 (Toyo ink). Four DHS fragments and roX2 promoter generated by PCR was constructed in BasicVector2 (45) . The heat shock promoter derived from pUAST was inserted into BasicVector2 and a reporter plasmid was generated (hs/BasicVector2). As an internal control vector, ß-galactosidase cDNA was inserted into pBlue-Actin5C.
GST pull down assay. The GST fusion proteins of each MLE2 mutant and the full length MLE were expressed in Escherichia coli strain TopXF' (Invitrogen) and purified using glutathione sepharose beads (Amersham Pharmacia Biotech). Then, 100 μg of nuclear extracts obtained from Shneider's cells (SL-2) were incubated with 2 μg of each GST fusion protein bound to resin in 1 ml of buffer A [50 mM HEPES (pH 7.9), 150 mM NaCl, 1 mM dithiothreitol (DTT), 1 mM EDTA, 1 mM MgCl 2 , 0.05% NP-40, 1 mM Na 3 VO 4 , 5 mM NaF, 1 μg/ml aprotinin, 1 μg/ml leupeptin, and 1 μg/ml pepstatin A] for 4 h at 4˚C. After washing with buffer A, the bound proteins were fractionated by SDS-PAGE and analyzed by Western blotting with antibodies against the largest subunit of RNA polymerase II (ARNA-3) (Progen) or MSL-1 antibody.
Yeast transactivation assay. The yeast strain Y190 was transformed with RHA deletion mutants using the lithium acetate method and transformants were selected on tryptophanfree agar plates for 3 days. For the liquid ß-gal assay, 1 ml of growth media was inoculated with selected colonies. The assay was performed in triplicate to quantify transcriptional activity as described previously (46) .
Localization of GFP fusion proteins. SL-2 cells were transfected with 2 μg of each construct using CellFectin reagent (Invitrogen). At 24 h after transfection, cells were seeded onto 14-mm 2 coverslips and incubated for 2 h. Cells were washed 3 times with PBS and fixed with 3.7% formaldehyde and Tween-20 in PBS for 30 min at room temperature. After removal of formaldehyde, cells were washed with PBS. DNA was counterstained with DAPI for 10 min and washed with PBS and Tween-20, then the coverslips were mounted and analyzed by microscopy system (Leica).
Reporter assay. SL-2 cells (1.2x10 5 ) were plated in a 24-well plate. The cells were transiently transfected with 50 ng of each mutant of MTAD fused to GAL4-DBD, or the empty vector alone, and 5 ng of G14-ts/BasicVector2 using CellFectin. Following 30 h of incubation, cells were lysed with cell lysis buffer (Promega) and luciferase activities were measured. The measured activity was normalized for ß-gal activity using cotransfected ß-galactosidase derived by Actin-5C promoter as a control. Each experiment was performed in triplicate. For assay with the reporter plasmid of MLE target promoter, SL-2 cells were cotransfected with 10 ng of DHSroX1, ProX2(-) or 1 ng of heat shock reporter plasmid, and 25 or 50 ng of MLE mutant expression vector. Cells were co-transfected with 25 ng Actin5C ß-gal as a control. The total amount of expression vector was kept constant by adding appropriate amounts of the empty vector pBlue-Actin5C.
Results
We reported previously that the transactivation domain of RHA consists of 50 amino acids termed MTAD. The MTAD interacts with Pol II complexes and activates CREBdependent transcription. The sequence of this domain is well conserved among RHA homologues from fly to human (Fig. 1A) (39) .
We examined whether the functions of the MTAD as well as the amino acid sequences are conserved in the homologues. The transactivation assay with the MTAD of Caenorhobditis elegans RHA (426-474 aa) and Drosophila MLE (325-376 aa) fused to GAL4 DBD was performed in yeast and mammalian cells. In yeast, C. elegans MTAD and MLE MTAD were activated 5-or 3-fold more than GAL4 DBD alone, respectively, although their activities were lower than that of human RHA (Fig. 1B) . Similar to the results in yeast, MTAD of C. elegans and MLE activated 12-or 13-fold more than empty vector, respectively (Fig. 1C) . These results suggested that the function of MTAD as a transcriptional activator could be conserved beyond species.
To determine whether the MTAD functions in vivo as a transcriptional regulator beyond the species, we generated a transgenic fly with mle deleted MTAD (ΔMTAD) and performed complementation experiments. It has been reported that male homozygous for the spontaneous null mle mutant, named mle 1 , die at larval stage (27) . The wild-type mle transgene fully complements the mutant phenotype (7), while the transgene lacking the ATP binding activity can not and the mutant die during the mid-to late-larval stage (26) . We examined whether the transgene carrying deletion of that MTAD in mle was allowed to rescue the phenotype of null mutant. The 10.2-kb fragment containing the full-length mle gene and its flanking sequence was used as the transgene (7). The mle ΔMTAD transgene was deleted from the amino acid region 326 to 378 in the 10.2 kb fragment. The mle null mutant fly with the wild-type or mle ΔMTAD transgene were generated. As reported previously, the wild-type mle transgene rescued the lethality of mle null mutant, whereas the mle null mutant with mle ΔMTAD transgene died during late larval stages similar to mle 1 in the three independent lines. These results indicate that the MTAD region could be essential for the viability of mle flies.
Drosophila SL-2 cells derived from early embryo are commonly used as a model system for studying male functions. We examined the effects of MTAD on trans- activation using SL-2 cells. To confirm that MTAD has transcriptional activity in Drosophila cells, transactivation assay was performed in SL-2 cells. The wild-type MTAD of MLE fused with GAL4 DBD driven from Drosophila Actin5C promoter-activated transcription 11-fold more than an empty vector. We reported previously that three tryptophan residues at amino acids 332, 339 and 342 in MTAD of RHA are important for transactivation (47) . To assess the functions of these conserved tryptophan residues in MLE, we fused a series of mutants with substitutions of tryptophan at amino acids 328, 335 and 338 with alanine, leucin and phenylalanine, with GAL4-DBD for transactivation assay. Mutants with substitutions of alanine or leucine exhibited only 35% of the transcriptional activity, compared with the wild-type MTAD. The mutants with substitution of phenylalanine retained higher activity, relative to that of mutants with substitution of other amino acids. Furthermore, substitutions of all tryptophan residues with alanines decreased the transcriptional activity to the same level as GAL4 DBD only (Fig. 2) . These results suggest that the MTAD region of MLE also plays a role as a transactivation domain in SL-2 cells and that tryptophan residues are also important for the function of MTAD.
To test whether MLE recruits Pol II, a GST pull down assay was performed with MLE full-length and MLE2 region (219-653 aa) containing the MTAD region fused to GST. MLE bound with the hyperphosphorylation form of Pol II (Pol IIO) and the hypophosphorylation form of Pol II (Pol IIA) complexes, while GST alone did not (Fig. 3A) . These results indicate that MLE interacted with both the elongation and initiation forms of Pol II. Furthermore, to confirm that the MTAD of MLE associates with Pol II complexes, we performed GST pull down assay with MLE2-deleted MTAD region (MLE2ΔMTAD) and in which three tryptophan residues were substituted with alanines (MLE2AAA). Similar to RHA, MLE2ΔMTAD and MLE2AAA did not interact with Pol II (Fig. 3B) . These results indicate that MLE recruits Pol II through MTAD.
Then, we examined the localization of each mutant in cells, since deletion of a domain may affect the localization and functions. Each mutant of MLE was expressed as GFP fusion protein in SL-2 cells. The GFP was distributed throughout the whole cells, whereas the wild-type MLE accumulated also in some parts of the nucleus. It is known that mutants lacking the ATP binding ability colocalize with MSL-1 in immunostaining of the salivary gland (25) . As reported previously, the mutant with substitution in the ATP binding site (MLEGET) was located in the nucleus similar to the wild-type. Surprisingly, MLEΔMTAD showed both nuclear and cytoplasmic distribution, while MLEAAA was located in the nucleus similarly to the wild-type. We reported previously that RHA has the nuclear localization signal in the C terminal region (41) . To confirm whether the NLS of MLE locates in the MTAD, we assessed the localization of the deletion mutants including the MTAD (MLE2) and lacking the C-terminal region from 1163 to 1287 aa (MLEΔEN). Both mutants were also localized in the cytoplasm similar to RHA (Fig. 4) . These results indicated that MLE could have the NLS in its C-terminal region not in the MTAD, and showed that MTAD may play a role in intracellular distribution of MLE.
To confirm the contribution of MTAD to MLE-dependent gene expression, we examined the effects of the full-length MLE on the promoter of its target genes using the reporter assay. The DCC is known to activate the expression of roX1 and roX2 genes, which are one of the chromatin entry sites on X chromosome, through binding to the DHS in those genes (18, 21) . We utilized the promoter region of roX1 fused to DHS, which locates at the center of roX1 gene (18) as a DCC target gene. The roX1 promoter (ProX1) with the DHS was activated 2-fold higher than with ProX1 only. Thus, MLE had only slight effect on the transactivation derived from roX1 promoter (ProX1), while MLE activated the DHS dependent transcription 1.5-fold higher than the empty vector (Fig. 5A) .
MLE belongs to an ATPase/helicase family and contains conserved ATP binding motifs. The enzymatic activity of MLE is essential for its functions in vivo (26) . As expected, MLE mutant lacking the ATP binding ability (MLEGET) could not activate. The mutants lacking the Pol II binding ability (MLEΔMTAD and MLEAAA) activated to the same levels as the empty vector. Then, we examined the effects of MTAD on transcription of MLE-regulated promoters. It was reported that MLE is recruited to the promoter of roX2 gene. The roX2 gene contains the MLE binding site to which MSL-1 does not interact in addition to the DHS (45) . Moreover, a previous study indicated that MLE localizes on the heat shock gene cluster of chromosome 3, which show a localization pattern independent of the DCC (48) . In this assay, we used the hypothetical promoter region (ProX2) of the roX2 gene at -207 to 92 lacking the DHS [ProX2(-)] (45) and the heat shock promoter (hsp70) as the reporter. The wild-type MLE-activated ProX2 and heat shock promoters by 1.5-or 2-fold compared to empty vector, respectively. The activities derived from MLEGET and MLEAAA were reduced to 50% of the levels induced by wild-type MLE. The activity of MLEΔMTAD was lower than the empty vector ( Fig. 5B and C) . These results suggest that MTAD, especially tryptophan residues, are important for transactivation of MLE target genes. 
A B C Discussion
In this study, we confirmed the functions of Drosophila MTAD of MLE on transactivation in fruit fly cells. In vivo, the wild-type MLE complemented the spontaneous MLE null mutant, while MLEΔMTAD failed to rescue the lethality. In SL-2 cells, this domain exhibited transcriptional activity (Fig. 2) and ability for recruitment of Pol II (Fig. 3) . MLE regulated the transactivation of the target genes through MTAD (Fig. 5) . The DCC is sequentially formed and recruited to the target genes on X chromosome. After activating the expression of the target genes driven from the high affinity entry site, the DCC spreads onto the low affinity sites of the X chromosome (19) . There is much progress in our understanding of the interactions, functions of MSLs and roX RNAs and mechanisms of each step in dosage compensation. MLE seems essential for the survival of male fly and its enzymatic activities are necessary for its roles (26, 27) . MLE, MOF and MSL-3 cooperate with each other for the formation of the DCC and localization on the X chromosome (24) . In addition to the in vivo data, it was reported that MLE is recruited to the roX2 gene promoter and activates the transcription (21, 45) . However, there is little information on the functions of MLE in the DCC on the tansactivation step, including initiation and elongation, or the spreading step in the dosage compensation. In the present study, MTAD was confirmed to have transcriptional activity (Fig. 2) and the results indicated that three tryptophan residues in MTAD are important for association with Pol II (Fig. 3) . These results suggest that MLE acted as a recruiting factor for the general transcriptional machinery to the DCC or X chromosome. It is also reported that MSL-2 fused to GAL4-DBD has transcriptional activity (49) . These findings allow us to speculate on some possibilities in transactivation mechanism through the DCC. MLE and MSL-2 may act as activators synergistically or MSL-2 as a scaffold factor and recruit MLE. The mechanisms of recruitment of Pol II may be different between the core complex, which comprises of only MSL-1 and MSL-2, and the mature DCC that includes all components. In addition, the roles of ATPase and helicase activity in the dosage compensation remain poorly understood. More detailed analysis is needed to understand the transactivation mechanisms.
In this study, we confirmed the distribution of each MLE mutant in SL-2 cells. In Fig. 4 , the wild-type MLE was detected in the nucleus. The mutant with deleted MTAD was defused throughout the whole cells. In our previous study, we indicated the effects of various functional domains in RHA on the nuclear localization. The wild-type RHA was located in the nucleus, while RHAW339A lacking the Pol II binding ability was partially localized in the cytoplasm. These results suggest that the MTAD may contribute to the retention in the nucleus (50) . Furthermore, the Pol II binding ability may be important for the localization in the nucleus. Since the NLS of MLE is located in the C-terminus, similar to RHA (Fig. 4) , it is thought that MLE can be imported into the nucleus but not retained there. It was reported that deletion of roX1 and roX2 genes lead to mis-location of the DCC in cells (51) . It has also been speculated that the MTAD could work as a nuclear retention signal, from the mature DCC on X chromosome or have unknown functions in addition to transactivation in cells.
Several studies have emphasized the multi-functional roles of MLE in gene expression as well as gene dosage compensation in male flies. Recently, studies using immunostaining and ChIP assay revealed that the localization of components were related to the dosage compensation on chromosomes (52) (53) (54) (55) . Immunostaining of polytene chromosome showed the DCC colocalizes with a subset of Pol IIO on the X chromosome in male flies, although the DCC does not associate with all transcriptional active sites (48) . Acetylation of K16 in histone H4 is found in the coding regions and 3' end of X-chromosomal genes (52) . However, there is no information on the localization of Pol IIA on X chromosome, due to the use of anti-Pol II antibody against all forms or the elongation form. Moreover, the majority of MSL-1 binding sites on the X chromosome are not consistent with the Pol II binding sites (52) . Taken together, we consider that the DCC is rather important for the spreading of the DCC and elongation than initiation. In our study, MLE interacted also with Pol IIO but mainly with Pol IIA. It is known that some factors, such as LMP2 (low molecular mass polypeptide 2), function not only during transcription initiation but also during transcription elongation (56) . We speculate that MLE included in the DCC could associate with the Pol IIO and regulates elongation, whereas the single MLE not as a complex may recruit Pol IIA to the promoters and activate the transcription (Fig. 6) . Future studies should determine the steps at which each component of the DCC works.
In mammalian cells, RHA has certain functions in gene expression. Our study showed that RHA interacts with various transcriptional activators including CBP. It acts as a coactivator recruiting general transcriptional factors such as Pol II and mediates transactivation (34, 39) . In the present study, the results suggest that Drosophila homologue MLE activated transcription, through Pol II to the target genes similar to RHA. MLE is also suggested to have additional functions independent of the DCC in transactivation. MLE activated the transcription derived from the heat shock promoter, whereas other components of the DCC, msl-1, msl-2 and msl-3, had only slight effects (Fig. 4) . These data are consistent with previous reports (48) . MLE is found in puffs in which the DCC does not localize. In female, MLE is detected on some sites more strongly than in male. Furthermore, it localizes in the puffs of autosomal chromosomes as well as on X chromosome. These puffs include a cluster of hsp70 genes (48) . These results suggest that MLE could work in trans-activation alone not as a component of the DCC. In mammalian cells, RHA is known to activate transcription through binding to the promoter as well as binding with transcription factors (33, 57) . It was reported that MLE promotes expression of roX2 gene through the element that does not include DHS on ProX2 promoter (45) . These data suggest that MLE, unlike the DCC, could have transactivation functions. RHA has many roles not only in transcription but also in transportation of viral RNAs and translation (33, (58) (59) (60) . In addition, a new function of RHA was identified recently; RHA is a component of RISC (RNAinduced silencing complex) and promotes the assembly of the complex (61) . The functional domains of MLE are well conserved between RHA and MLE (39) . These findings allow us to speculate that various functions of RHA are also conserved in MLE. Exploring the associating factors with MLE should enhance our understanding of the transcriptional mechanisms, furthermore to understand the regulation mechanisms of gene expression in eukaryotic cells.
